Clinical Trial Update: Fluorescence-guided Resection in Breast Cancer [Phase 2]

View source ↗

Summary

The Phase 2 trial evaluating fluorescence-guided resection for breast cancer (NCT01110954) sponsored by photonamic GmbH & Co. KG has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: photonamic GmbH & Co. KG | Conditions: Breast Tumour | Phase 2 | Status: TERMINATED